It’s never fun to admit you’re wrong, but anyone who has been involved in the markets for years knows that, much like in baseball, failure is more common than success. Last year, my 5 Biotech Predictions for 2016, was filled with failure, including a doozy of a prediction that GW Pharmaceuticals plc (NASDAQ:GWPH) shares would slide (spoiler alert: they soared). Here are my biggest prediction gaffes in 2016, and a couple I got right, more or less.
